The Eli Lily & Company just announced that they will be expanding in New York City. They will be adding a 30,000 square feet at the Alexandria Center for Life Science in 450 East 29th Street. This is a biotech center in New York.
According to The Real Deal, this expansion in New York will open roughly 50 new job vacancies and a bigger space for additional research. It has been reported by The Wall Street Journal that the additional research space will be used for research works focusing on the immune system and cancer treatments.
Jan Lundberg the President of Lilly Research Labs told WSJ that "Our diverse research approach and expansion in New York will ultimately put us in a strong position to advance the delivery of innovative medicines to patients."
According to PR Newswire, upon its completion in 2016 the research area will be used as a "portal" wherein it will provide "local scientists a collaborative access to cutting-edge drug discovery capabilities, including chemistry and lead optimization expertise."
Lundberg also shared that, "Going forward, immuno-oncology research will focus on new ways to harness the immune system and on combination therapies with targeted agents." He added, "Cancer is a complex disease. Our diverse research approach and expansion in New York will ultimately put us in a strong position to advance the delivery of innovative medicines to patients."
It is a great move for Eli Lily to expand because this will help strengthen their relationship with local academic institutions as well as prominent medical schools in the country. Given this, increased collaboration can definitely help in the discovery and development of new medicines which includes "oncology, diabetes and related complications, neurodegeneration, immunology and pain."
According to Lundberg they are ready to push boundaries in order to help increase drug discovery. Lundberg said, "Our expanded capabilities at the New York site will further Lilly's expertise in our core therapeutic areas and help pave the way for broader collaboration with leading academic, health care and industry colleagues."
